NYXH Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

1.699

Open

1.699

VWAP

1.56

Vol

878.61K

Mkt Cap

128.72M

Low

1.440

Amount

1.37M

EV/EBITDA(TTM)

Total Shares

44.69M

119.87M

EV/OCF(TTM)

P/S(TTM)

6.34

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Events Timeline

(ET)

2026-06-05

11:40:00

New

Nyxoah Plans to Close Offering Around June 9

2026-06-05

10:00:00

Nyxoah S.A. Trading Halted, News Pending

2026-06-04 (ET)

2026-06-04

16:10:00

Nyxoah Initiates Leadership Transition, Searching for U.S.-Based CEO

2026-06-04

16:10:00

Nyxoah SA Launches Underwritten Public Offering in the U.S.

2026-05-12 (ET)

2026-05-12

17:10:00

Nyxoah Reports Q1 Revenue of €6.37M

News

8.5

17:10 PMstocktwits

Nyxoah Plans $95 Million Public Offering to Expand U.S. Operations

8.5

15:43 PMNewsfilter

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

8.5

06-04seekingalpha

Nyxoah Launches Proposed Public Offering in the U.S.

8.5

05-20Newsfilter

Nyxoah Discloses Voting Rights and Share Information

9.5

03-20Yahoo Finance

Nyxoah Secures FDA Approval and Successful U.S. Launch

2.0

03-20NASDAQ.COM

Nyxoah (NYXH) Q4 2025 Earnings Call Transcript

5 Analyst Rating

Wall Street analysts forecast NYXH stock price to rise

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

5.82

Averages

10.41

High

13.00

Current: 0.000

Low

5.82

Averages

10.41

High

13.00

Piper Sandler

Overweight

downgrade

$9 -> $7

AI Analysis

2026-05-13

Reason

Piper Sandler

Price Target

$9 -> $7

AI Analysis

2026-05-13

downgrade

Overweight

Reason

Piper Sandler lowered the firm's price target on Nyxoah to $7 from $9 and keeps an Overweight rating on the shares following quarterly results. Genio launch appears to be progressing well with U.S. net-revenue up 25% quarter-over-quarter and consistent with company expectations, the firm notes. Piper continues to believe Nyxoah has the potential to become a high-growth asset, though it acknowledges the balance sheet will likely need to be bolstered some.

Stifel

Buy

Hold

downgrade

$8 -> $5

2026-05-11

Reason

Stifel

Price Target

$8 -> $5

2026-05-11

downgrade

Buy

Hold

Reason

Stifel downgraded Nyxoah (NYXH) to Hold from Buy with a price target of $5, down from $8. The downgrade is not specific to the Q1 earnings announcement due tomorrow after market close, but a belief that hypoglossal nerve stimulation reimbursement challenges persist for the balance of the year, the analyst tells investors. The firm would \"only want one horse in a challenging HGNS market\" and would select Inspire Medical (INSP) over Nyxoah, says the analyst, who keeps a Buy rating and $65 price target on Inspire shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NYXH

Unlock Now

Valuation Metrics

The current forward P/E ratio for Nyxoah SA (NYXH.O) is 0.00, compared to its 5-year average forward P/E of -5.40. For a more detailed relative valuation and DCF analysis to assess Nyxoah SA's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-5.40

Current PE

0.00

Overvalued PE

-0.42

Undervalued PE

-10.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-4.21

Current EV/EBITDA

-0.70

Overvalued EV/EBITDA

-0.19

Undervalued EV/EBITDA

-8.22

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

30.00

Current PS

1.87

Overvalued PS

57.87

Undervalued PS

2.14

Financials

AI Analysis

Annual

Quarterly

Whales Holding NYXH

Trading Trends

People Also Watch

Frequently Asked Questions

What is Nyxoah SA (NYXH) stock price today?

The current price of NYXH is 1.54 USD — it has decreased -46.53

What is Nyxoah SA (NYXH)'s business?

What is the price predicton of NYXH Stock?

Wall Street analysts forecast NYXH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NYXH is10.41 USD with a low forecast of 5.82 USD and a high forecast of 13.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nyxoah SA (NYXH)'s revenue for the last quarter?

Nyxoah SA revenue for the last quarter amounts to 6.37M USD, increased 498.87

What is Nyxoah SA (NYXH)'s earnings per share (EPS) for the last quarter?

Nyxoah SA. EPS for the last quarter amounts to -0.37 USD, decreased -38.33

How many employees does Nyxoah SA (NYXH). have?

Nyxoah SA (NYXH) has 147 emplpoyees as of June 05 2026.

What is Nyxoah SA (NYXH) market cap?

Today NYXH has the market capitalization of 128.72M USD.

NYXH Overview

NYXH Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding NYXH

Trading Trends

People Also Watch

Frequently Asked Questions

What is Nyxoah SA (NYXH) stock price today?

What is Nyxoah SA (NYXH)'s business?

What is the price predicton of NYXH Stock?

What is Nyxoah SA (NYXH)'s revenue for the last quarter?

What is Nyxoah SA (NYXH)'s earnings per share (EPS) for the last quarter?

How many employees does Nyxoah SA (NYXH). have?

What is Nyxoah SA (NYXH) market cap?